FundLens
40
Pharma & HealthcareAvoid

Tata India Pharma & Healthcare

Tata · Direct–Growth · rank #12 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
10.7%
+10.0% vs index
3 Years
18.4%
+6.8% vs index
5 Years
15.8%
+5.7% vs index
Since launch
13.5%

Year-by-year performance

last entry = YTD
2021
+20.9%
2022
-6.6%
2023
+38.6%
2024
+42.5%
2025
-3.5%
2026
+12.7%

Why this score

Tata India Pharma & Healthcare scores 40/100 — #12 of 19 Pharma & Healthcare fund (Avoid). It stands out for volatility and alpha — beating 78% of peers on volatility. The main drag is its 3y return (better than only 13% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

3Y return18.36% · 13th percentile in category
5Y return15.79% · 35th percentile in category
Volatility13.36 · 78th percentile in category
Alpha7.81 · 78th percentile in category
1Y return10.71% · 9th percentile in category
Fund size1499.15 Cr · 66th percentile in category

Top holdings

top 5 = 29.4% of portfolio
1.Sun Pharmaceutical Industries Ltd7.89%
2.Abbott India Ltd5.66%
3.Divi's Laboratories Ltd5.41%
4.Healthcare Global Enterprises Ltd5.25%
5.Dr. Reddy's Laboratories Ltd5.14%

40 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds